After Decades of Delays, RSV Vaccines Show Promise in Early Data
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
After Decades of Delays, RSV Vaccines Show Promise in Early Data
After Decades of Delays, RSV Vaccines Show Promise in Early Data
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
Both Pfizer and GSK have shared preliminary data suggesting that their experimental vaccines can protect older adults and newborn infants from the virus.
An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.
The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.